Surendralal Lanca Karsanbhai
Director · Merck & Co., Inc.
- 2024
- Oct 1, 2026
- 18
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Surendralal Lanca Karsanbhai files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jennifer Zachary - $25.20M in MRK purchases and sales in the last 12 months
- Richard R. Deluca - $11.29M in MRK purchases and sales in the last 12 months
- Chirfi Guindo - $8.15M in MRK purchases and sales in the last 12 months
- David Michael Williams - $8.13M in MRK purchases and sales in the last 12 months
- Robert M. Davis - $5.60M in MRK purchases and sales in the last 12 months
- Caroline Litchfield - $5.02M in MRK purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Surendralal Lanca Karsanbhai?
Surendralal Lanca Karsanbhai is a corporate insider, tracked as Director of Merck & Co., Inc. (MRK). InsiderAlpha holds 18 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Surendralal Lanca Karsanbhai submitted recently?
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Has Surendralal Lanca Karsanbhai been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($10.18M) across all tracked filings.